Teladoc Health disclosed its second-quarter 2026 financial results in a filing dated July 30, 2026, covering the period ended June 30, 2026. The filing provides updated balance sheet data, intangible asset valuations, and debt structure information for the telehealth and integrated care platform operator. Investors monitoring the company's financial health and capital structure will find detailed disclosures on convertible notes, revolving credit facilities, and segment performance metrics.

Key Points

  • NYSE: TDOC
  • Teladoc Health filed updated financial statements for the six-month period ended June 30, 2026
  • The company maintains convertible senior notes due in 2027 and a revolving credit facility with pricing tied to secured overnight financing rates
  • Intangible assets including customer relationships, trademarks, software, and technology-based assets are disclosed with amortization schedules through the end of 2026

Balance Sheet and Capital Structure Disclosed

Teladoc Health's financial disclosure reveals the company's capital composition as of June 30, 2026. The filing includes detailed equity information across common stock, additional paid-in capital, retained earnings, and accumulated other comprehensive income accounts. The company's balance sheet reflects positions as of both the current period end and prior year-end December 31, 2025, allowing investors to assess period-over-period changes in financial position. The disclosure structure indicates ongoing management of shareholder capital and retained earnings allocation across the six-month period.

Convertible Notes and Debt Obligations

The filing confirms Teladoc Health carries convertible senior notes due in 2027, originally issued on May 19, 2020. These notes remain a significant component of the company's capital structure as disclosed through June 30, 2026. The convertible debt obligation is tracked separately in consolidated financial statements, with detailed accounting treatment reflected throughout the interim period. The notes represent a key financing mechanism for the company and remain material to its balance sheet composition heading toward the 2027 maturity date.

Revolving Credit Facility Terms and Pricing

The company disclosed details of its revolving credit facility, with pricing mechanisms tied to secured overnight financing rates (SOFR) and federal fund rates as of July 17, 2025. The facility includes defined minimum and maximum pricing thresholds, reflecting typical credit agreement structures. The revolving credit arrangement provides liquidity flexibility for operational and strategic needs. The filing indicates the facility remains active and available to support the company's working capital requirements during the disclosed period.

Intangible Assets and Amortization Schedule

Teladoc Health disclosed significant intangible assets as of June 30, 2026, including customer relationships, trademarks, software and software development costs, and technology-based intangible assets. The filing details weighted average useful lives for amortization purposes, with schedules projecting amortization through the end of 2026. These intangible assets reflect prior business acquisitions and are material to the company's consolidated balance sheet valuation. Investors tracking asset quality and future expense recognition should monitor the disclosed amortization timelines.